2022 annual financial data

Sutro Biopharma 2022 Operating margin

Direct answer

Operating margin was -190.26%.

Operating income was -128.94M USD and net income was -119.2M USD.
Operating cash flow was 3.55M USD.

Get free Sutro Biopharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
67.77M USD
Operating income
-128.94M USD
Net income
-119.2M USD
Operating cash flow
3.55M USD